$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Blueprint Medicines Corporation (NASDAQ: BPMC)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 14 2025
0mins
Source: Globenewswire
Class Action Firm Overview: Monteverde & Associates PC, led by attorney Juan Monteverde, is recognized as a top firm for recovering millions for shareholders and is currently investigating the sale of Blueprint Medicines Corporation to Sanofi, which includes a cash offer and potential milestone payments for shareholders.
Contact Information: The firm invites shareholders with concerns about the transaction to reach out for free information, emphasizing their successful track record in class action lawsuits from their headquarters in the Empire State Building.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
